Curacle Co. Ltd. inked a potential $1.07 billion deal with U.S.-based “newco” Memento Medicines on May 10, granting the latter exclusive global rights to develop and commercialize preclinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results